Which drug-induced side effects would be tolerated in the prospect of seizure control?

Epilepsy and Behavior

Volumn 29, Issue 1, 2013, Pages 141-143

  Witt, Juri Alexander ^a   Elger, Christian E ^a   Helmstaedter, Christoph ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Adverse events; Antiepileptic drugs; Cognition; Irritability; Memory; Mood; Seizure control; Treatment emergent side effects

Indexed keywords

ANTICONVULSIVE AGENT;

AGITATION; ALERTNESS; ANTICONVULSANT THERAPY; ARTICLE; CONCENTRATION LOSS; DEPRESSION; DISEASE CONTROL; DISEASE SEVERITY; DRUG TOLERANCE; FATIGUE; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MEMORY DISORDER; OUTCOME ASSESSMENT; SEIZURE; SEXUAL DYSFUNCTION; SIDE EFFECT; SKIN IRRITATION; SLEEP DISORDER; WEIGHT GAIN;

ADVERSE EVENTS; ANTIEPILEPTIC DRUGS; COGNITION; IRRITABILITY; MEMORY; MOOD; SEIZURE CONTROL; TREATMENT-EMERGENT SIDE EFFECTS;

ANTICONVULSANTS; COGNITION DISORDERS; DRUG RESISTANCE; FEMALE; HUMANS; MALE; MENTAL DISORDERS; SEIZURES; SEVERITY OF ILLNESS INDEX;

EID: 84883000152     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2013.07.013     Document Type: Article

References (14)

1. Gilliam F.G., Fessler A.J., Baker G., Vahle V., Carter J., Attarian H. Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial. Neurology 2004, 62:23-27.
2. Bootsma H.P., Ricker L., Hekster Y.A., Hulsman J., Lambrechts D., Majoie M., et al. The impact of side effects on long-term retention in three new antiepileptic drugs. Seizure 2009, 18:327-331.
3. Kwan P., Brodie M.J. Neuropsychological effects of epilepsy and antiepileptic drugs. Lancet 2001, 357:216-222.
4. Trimble M.R. Anticonvulsant drugs and cognitive function: a review of the literature. Epilepsia 1987, 28:37-45.
5. Perucca P., Gilliam F.G. Adverse effects of antiepileptic drugs. Lancet Neurol 2012, 11:792-802.
6. Camfield P., Camfield C. Monitoring for adverse effects of antiepileptic drugs. Epilepsia 2006, 47(Suppl. 1):31-34.
7. Stavem K. Willingness to pay: a feasible method for assessing treatment benefits in epilepsy?. Seizure 1999, 8:14-19.
8. Eddy C.M., Rickards H.E., Cavanna A.E. Behavioral adverse effects of antiepileptic drugs in epilepsy. J Clin Psychopharmacol 2012, 32:362-375.
9. Mula M., Trimble M.R. Antiepileptic drug-induced cognitive adverse effects: potential mechanisms and contributing factors. CNS Drugs 2009, 23:121-137.
10. Witt J.A., Helmstaedter C. Monitoring the cognitive effects of antiepileptic pharmacotherapy - approaching the individual patient. Epilepsy Behav 2013, 26:450-456.
11. Hamer H.M., Dodel R., Strzelczyk A., Balzer-Geldsetzer M., Reese J.P., Schoffski O., et al. Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany - a nationwide population-based study in children and adults. J Neurol 2012, 259:2376-2384.
12. Strzelczyk A., Haag A., Reese J.P., Nickolay T., Oertel W.H., Dodel R., et al. Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany. Epilepsy Behav 2013, 27:433-438.
13. Panelli R.J., Kilpatrick C., Moore S.M., Matkovic Z., D'Souza W.J., O'Brien T.J. The Liverpool Adverse Events Profile: relation to AED use and mood. Epilepsia 2007, 48:456-463.
14. Wieshmann U.C., Tan G.M., Baker G. Self-reported symptoms in patients on antiepileptic drugs in monotherapy. Acta Neurol Scand 2011, 124:355-358.